against COVID-19. In the new building, he will oversee Penn’s Institute for RNA Innovation, which is developing the mRNA technology for other medical uses beyond vaccines. Until now, the institute was spread out over four locations on the university’s campus.“Everything will be in one place,” he said. “We’re still in the process of emptying boxes.”
The Penn physician said one of his non-vaccine projects involves marrying the mRNA platform with another cutting-edge technology that was developed at Penn — the cancer treatment nicknamed CAR-T.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: